(Q33605312)

28 July 2017

1 reference

title

Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations (English)

1 reference

28 July 2017

1 reference

Lavé T

1

1 reference

28 July 2017

Coassolo P

series ordinal

2

1 reference

28 July 2017

Reigner B

series ordinal

3

1 reference

28 July 2017

language of work or name

1 reference

1 March 1999

1 reference

Clinical Pharmacokinetics

28 July 2017

1 reference

28 July 2017

36

1 reference

28 July 2017

211-231

1 reference

28 July 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199936030-00003

28 July 2017

0 references

cites work

Dihydropyrimidine dehydrogenase inactivation and 5-fluorouracil pharmacokinetics: allometric scaling of animal data, pharmacokinetics and toxicodynamics of 5-fluorouracil in humans

1 reference

12 December 2020

A new extrapolation method from animals to man: application to a metabolized compound, mofarotene

1 reference

12 December 2020

Disposition of the selective alpha1A-adrenoceptor antagonist tamsulosin in humans: comparison with data from interspecies scaling

1 reference

12 December 2020

The use of human hepatocytes to select compounds based on their expected hepatic extraction ratios in humans

1 reference

12 December 2020

An evaluation of the integration of pharmacokinetic and pharmacodynamic principles in clinical drug development. Experience within Hoffmann La Roche

1 reference

12 December 2020

Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats

1 reference

12 December 2020

Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance.

1 reference

12 December 2020

Biodegradable microspheres. IV: Factors affecting the distribution and degradation of polyacryl starch microparticles

1 reference

12 December 2020

Interspecies scaling: predicting clearance of drugs in humans. Three different approaches

1 reference

12 December 2020

In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man

1 reference

12 December 2020

Interspecies scaling of the pharmacokinetic parameters of coumarin among six different mammalian species

1 reference

12 December 2020

Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach.

1 reference

12 December 2020

Pharmacokinetics of 2',3'-dideoxycytidine in rats: application to interspecies scale-up

1 reference

12 December 2020

Phencyclidine pharmacokinetic scaling among species.

1 reference

12 December 2020

Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans.

1 reference

12 December 2020

Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm

1 reference

12 December 2020

A size standard for pharmacokinetics.

1 reference

12 December 2020

Bosentan, a new endothelin receptor antagonist: prediction of the systemic plasma clearance in man from combined in vivo and in vitro data

1 reference

12 December 2020

Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species.

1 reference

12 December 2020

Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations.

1 reference

12 December 2020

Unbound total (plasma) clearance approach in interspecies pharmacokinetics correlation: theophylline-cimetidine interaction

1 reference

12 December 2020

Interspecies scaling of tebufelone pharmacokinetic data and application to preclinical toxicology

1 reference

12 December 2020

Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics

1 reference

12 December 2020

Interspecies scaling and comparisons in drug development and toxicokinetics

1 reference

12 December 2020

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data

1 reference

12 December 2020

Comparative pharmacokinetics and interspecies scaling of 3'-azido-3'-deoxythymidine (AZT) in several mammalian species

1 reference

12 December 2020

Extrapolation of preclinical pharmacokinetic data to therapeutic drug use.

1 reference

12 December 2020

Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver: studies with induced livers involving diazepam.

1 reference

12 December 2020

1 reference

12 December 2020

Interspecies scaling of a thienodiazepine platelet-activating factor receptor antagonist.

1 reference

12 December 2020

Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985)

1 reference

12 December 2020

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance

1 reference

12 December 2020

Interspecies scaling of bosentan, a new endothelin receptor antagonist and integration of in vitro data into allometric scaling

1 reference

12 December 2020

First-time-in-human dose selection: allometric thoughts and perspectives

1 reference

12 December 2020

Interspecies scaling of tolcapone, a new inhibitor of catechol-O-methyltransferase (COMT). Use of in vitro data from hepatocytes to predict metabolic clearance in animals and humans

1 reference

12 December 2020

Dependence of pharmacokinetic parameters on the body weight

1 reference

12 December 2020

Clearance approaches in pharmacology.

1 reference

12 December 2020

Quantitative Relations in the Physiological Constitutions of Mammals

1 reference

12 December 2020

Scaling basic toxicokinetic parameters from rat to man.

1 reference

12 December 2020

Predicting the hepatic clearance of xenobiotics in humans from in vitro data

1 reference

12 December 2020

Pharmacokinetic scale-up: accurate prediction of human pharmacokinetic profiles from animal data

1 reference

12 December 2020

Man versus beast: pharmacokinetic scaling in mammals

1 reference

12 December 2020

Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance

1 reference

12 December 2020

Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse

1 reference

12 December 2020

Interspecies pharmacokinetic scaling of metazosin, a novel alpha-adrenergic antagonist

1 reference

12 December 2020

The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.

1 reference

12 December 2020

Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor

1 reference

12 December 2020

Comparative pharmacokinetics of benzodiazepines in dog and man

1 reference

12 December 2020

Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patients.

1 reference

12 December 2020

Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins

1 reference

12 December 2020

Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling.

1 reference

12 December 2020

1 reference

12 December 2020

Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species.

1 reference

12 December 2020

Interspecies scaling of cimetidine-theophylline pharmacokinetic interaction: interspecies scaling in pharmacokinetic interactions.

1 reference

12 December 2020

Forecasting cephalosporin and monobactam antibiotic half-lives in humans from data collected in laboratory animals

1 reference

12 December 2020

Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs

1 reference

12 December 2020

Pharmacokinetics and interspecies scaling of recombinant human factor VIII.

1 reference

12 December 2020

Preclinical drug metabolism in the age of high-throughput screening: an industrial perspective

1 reference

12 December 2020

10.2165/00003088-199936030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference